Reducing HIV Risk Behaviors With Peer-Led Interventions

October 07, 1998

Drug users are at high risk for HIV infection because the virus can be spread through needle-sharing or the high-risk sex that some users exchange for drugs. Researchers from Washington University School of Medicine in St. Louis have been studying ways to help lower the risk. In the journal Public Health Reports, they report that a peer-led intervention program is having success for some behaviors, but getting users to engage in safer sex remains a problem. Linda Cottler, Ph.D., a professor of psychiatric epidemiology, and colleagues are targeting high-risk groups with programs to modify high-risk behaviors. She says such research to slow the spread of AIDS is essential because an effective vaccine is still years away.

"We know how AIDS is spread, and we know several ways to help lower individual risk, but still seven Americans become infected every hour. We need to develop more and better interventions to change those numbers," says Cottler.

Cottler and colleagues focused on a program they developed called EachOne TeachOne, funded by a grant from the National Institute on Drug Abuse (NIDA). In 1990, NIDA launched a multisite outreach program to reduce the spread of HIV among drug users, and each of the 23 sites has developed its own enhanced interventions to address the spread of AIDS in their communities.

The EachOne TeachOne program is a collaboration between Washington University and the St. Louis Health Department. The program recruits subjects from an area with an AIDS rate of almost 19 per 100,000 and a syphilis rate twice the national average and 60 times the national average among African Americans. It involves peer counselors in recovery from drug use, and the sessions cover drug awareness, stress management, AIDS and reducing high risk sexual behaviors such as having sex with multiple partners or failing to use a condom.

The investigators surveyed high-risk drug users at the beginning of the study and again, three months later, comparing results of those randomized to an enhanced intervention to results of those assigned to a standard intervention. The primary risk factors were drug use, number of sex partners and failure to use condoms both before and after the intervention.

Participants who engaged in high-risk behaviors less frequently than their peers, after three months, were considered improved. If, for instance, a crack cocaine user was still using but had cut back from several times a day to less than once a day, that person was classified as improved. Smoking crack about twice daily changed the user's classification to moderate risk. More than twice a day was considered highest risk.

The same system was used to measure the risk from multiple sex partners. One partner in the last 30 days equated with lower risk. A person who had two sex partners during the previous month was classified as moderate. Those with three or more sex partners were considered high risk.

"This study looks at this matrix of people, and it allows us to say who improved by comparing follow-up with baseline status," Cottler explains. "Crack cocaine users really do reduce their HIV risk by cutting back."

Cottler's team found that 80 percent of the participants either cut back on their drug use or maintained a low level of risk while taking part in the EachOne TeachOne program. In the area of sex partners, 75 percent had fewer or maintained a lower risk and were considered improved. But not all of the news was good.

"Condom use was the one area where we did not see relative improvements. To classify a participant as improved, they either had to abstain from sex or use condoms 100 percent of the time. Those who reported they didn't use condoms at all or used them only some of the time were classified as high risk. Using this definition, our overall sample worsened more than it improved in terms of condom use," Cottler explains.

Like investigators in other studies, Cottler and colleagues found it was easier for drug users to reduce their number of sexual partners than increase their frequency of condom use. For some reason, it is especially difficult to get people to change their sexual behaviors, but Cottler compares the problem to a diabetic managing blood glucose. Taking insulin shots, while important, does not entirely solve the problem. Patients also need to make dietary adjustments and monitor their glucose levels to maintain the proper balance. She says the EachOne TeachOne program also may need better balance.

Focus on drug use

Perhaps the intervention focuses on drugs in such a way that the participants think of sexual behaviors as secondary risk factors. On the other hand, Cottler believes it would be unwise to take the focus off drug use.

"Many of these people have used their sexual behaviors to get their drug. Even though we're currently doing a better job with drug use than with sex behaviors, we can't let up on the drugs. We just have to fight harder in the area of sexual behaviors," she argues.

Cottler remains convinced that even members of very high-risk groups can lower their risk of contracting AIDS. Therefore, the researchers are constantly reevaluating and measuring the effects of various interventions to learn which people they are reaching and which ones still are engaging in high-risk activities. Because their study measured not only outcomes but also the direction in which subjects were moving, Cottler says it may be possible to tweak the intervention to emphasize different messages for different risk groups.

"Behavior is the most important factor in preventing AIDS, and we know that changing behaviors is very difficult -- whether it's getting kids to clean their rooms or getting drug users to use condoms -- but changing behavior is essential if we hope to slow the spread of AIDS and other sexually transmitted diseases," she says.

Note: For more information, refer to: Cottler, LB., et. al, "Peer-Delivered Interventions Reduce HIV Risk Behaviors Among Out-of-Treatment Drug Abusers," Public Health Reports, vol. 113, Supplement 1, pp. 1-11, June 1998.
-end-


Washington University in St. Louis

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.